SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950135-08-003588
Filing Date
2008-05-09
Accepted
2008-05-09 14:34:42
Documents
5

Document Format Files

Seq Description Document Type Size
1 MOLECULAR INSIGHT PHARMACEUTICALS, INC. b70034misv3.htm S-3 166627
2 EX-5.1 LEGAL OPINION OF FOLEY & LARDNER LLP b70034miexv5w1.htm EX-5.1 8308
3 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b70034miexv23w1.htm EX-23.1 1757
4 GRAPHIC b70034mib7003401.gif GRAPHIC 3190
5 GRAPHIC b70034mib7003402.gif GRAPHIC 1012
  Complete submission text file 0000950135-08-003588.txt   184154
Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Filer) CIK: 0001340752 (see all company filings)

IRS No.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-150788 | Film No.: 08817760
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1